Filing Details

Accession Number:
0001127602-20-023455
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-08-12 16:36:30
Reporting Period:
2020-07-28
Accepted Time:
2020-08-12 16:36:30
Original Submission Date:
2020-07-29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
794172 Meridian Bioscience Inc VIVO In Vitro & In Vivo Diagnostic Substances (2835) 310888197
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1432665 Iii P Anthony Bihl 3471 River Hills Drive
Cincinnati OH 45244
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-11 5,000 $17.99 5,851 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Acquisiton 2020-07-28 4,595 $0.00 4,595 $23.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,595 2030-07-28 No 4 A Direct
Footnotes
  1. This $23.50 Exercise Price serves to correct/replace the $8.7058 that was incorrectly reflected on the original Form 4 filed July 29, 2020.
  2. These options awarded under the 2012 Stock Incentive Plan vest 25% every 45 days from the date of grant.